4.8 Article

Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder Masquerading as Multiple Sclerosis: An Under-Recognized Entity?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

John J. Chen et al.

NEUROLOGY (2020)

Article Clinical Neurology

Atypical MOG antibody disease presenting with typical multiple sclerosis lesions

Katelyn Dolbec et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Article Clinical Neurology

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients

Daniel H. Whittam et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Article Clinical Neurology

A multicenter comparison of MOG-IgG cell-based assays

Patrick J. Waters et al.

NEUROLOGY (2019)

Editorial Material Clinical Neurology

MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing?

Marianthi Breza et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)

Article Clinical Neurology

Neurological update: MOG antibodydisease

Ray Wynford-Thomas et al.

JOURNAL OF NEUROLOGY (2019)

Review Clinical Neurology

Rituximab in neurological disease: principles, evidence and practice

Daniel H. Whittam et al.

PRACTICAL NEUROLOGY (2019)

Review Clinical Neurology

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations

Maciej Jurynczyk et al.

PRACTICAL NEUROLOGY (2019)

Article Clinical Neurology

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

Sudarshini Ramanathan et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Article Clinical Neurology

Clinical presentation and prognosis in MOG-antibody disease: a UK study

Maciej Jurynczyk et al.

Article Clinical Neurology

Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders

Eoin P. Flanagan et al.

JAMA NEUROLOGY (2015)

Article Rheumatology

Low- Versus High-Dose Rituximab for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

Markus Bredemeier et al.

ARTHRITIS CARE & RESEARCH (2014)